MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+28.77%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$190M
AUM Growth
+$190M
(+31%)
Cap. Flow
+$17.3M
Cap. Flow
% of AUM
9.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Exelixis
EXEL
|
$16.8M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
$480K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $124M | 65.29% | 22,070,213 +3,000,000 | +16% | +$16.8M |
|
2
Alkermes
ALKS
$4.78B
| $60.5M | 31.89% | 1,030,639 | – | – |
|
|
VVUS
3
DELISTED
Vivus Inc
VVUS
| $4.86M | 2.57% | 2,965,616 | – | – |
|
|
4
Rocket Pharmaceuticals
RCKT
$354M
| $480K | 0.25% | +51,111 | New | +$480K |
|